Compare Ekadharma International Tbk. (EKAD) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ekadharma International Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Ekadharma International Tbk. trades at Rp170 (market cap 590.46B, 90.5K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp146 (market cap 584.6B, 817.3K 24h volume). The key difference: Ekadharma International Tbk. and UBC Medical Indonesia Tbk. are close in size by market cap, and UBC Medical Indonesia Tbk. is more actively traded (817.3K versus 90.5K). Which is the better fit depends on your goals.
| EKAD | LABS | |
|---|---|---|
Market Cap | 590.46B | 584.6B |
Volume | 90.5K | 817.3K |
Lot | 905 | 8.17K |
Turnover | 15.24M | 120.01M |
Average Price | 168.44 | 146.84 |
Value | 15.24M | 120.01M |
Indicative Equilibrium Price | 170 | 146 |
Indicative Equilibrium Volume | 5 | 59 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ekadharma International Tbk.
PT Ekadharma International Tbk (the Company) was established under the name of PT Ekadharma Widya Graphika based on Notarial Deed No. 71 dated November 20, 1981. PT Ekadharma Tape Industries Tbk manufactures computer continuous form paper and other related products. It also holds a manufacturing and distribution license from Nashua Corporation, USA.In August 2, 2006, The company's name was changed to PT Ekadharma International Tbk.
Read more on EKAD →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
